Swiss National Bank Durect Corp Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.9 - $1.31 $452,250 - $658,275	-502,500 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$1.21 - $1.61 $18,876 - $25,116	15,600 Added 3.2%	502,500 $643,000
Q2 2021 Aug 06, 2021	BUY	$1.6 - $2.02 $36,320 - $45,854	22,700 Added 4.89%	486,900 $794,000
Q1 2021 May 07, 2021	BUY	$1.86 - $2.87 $19,902 - $30,709	10,700 Added 2.36%	464,200 $919,000
Q4 2020 Feb 05, 2021	BUY	$1.65 - $2.43 $27,060 - $39,852	16,400 Added 3.75%	453,500 $939,000
Q2 2020 Aug 05, 2020	BUY	$1.33 - $2.76 $581,343 - $1.21 Million	437,100 New	437,100 $1.01 Million

591K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $255M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.